Prosecution Insights
Last updated: April 19, 2026

2N Pharma Aps

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18558763 Diazepane Derivatives, Processes for their Preparation, and Uses thereof for the Amelioration, Prevention and/or Treatment of Mental and Neurological Diseases MOTEVALLI, OROD 1628 Non-Final OA Nov 03, 2023

Managing 2N Pharma Aps's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month